62 results on '"Arat, Mutlu"'
Search Results
2. Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics
3. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
4. Current practice of oral care for hematopoietic stem cell transplant patients: A survey of the Eastern Mediterranean Blood and Marrow transplantation group
5. Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
6. Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation
7. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
8. Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party
9. Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic Leukemia
10. Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT
11. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p
12. 32 - Non T–Cell Depleted Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia in Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
13. Effects of plasma nitric oxide levels on platelet activation in single donor apheresis and random donor concentrates
14. Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra
15. How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight
16. Apheresis information management system (AMIS)
17. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: Review of 50 cases
18. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD)
19. Does continuous flow apheresis influence viability in allogeneic hematopoietic stem cell harvest?
20. Risk Factors Influencing Transplant Outcomes of Adults with Acute Lymphoblastic Leukemia in First Complete Remission: A Retrospective Analysis from the ALWP of the EBMT
21. Effects of replacement fluids used for therapeutic plasma exchange on plasma viscosity and plasma oncotic pressure
22. Therapeutic plasma exchange in a single center: Ibni Sina experience
23. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease
24. Peripheral blood stem cell apheresis for allogeneic transplants: Ibni Sina experience
25. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy
26. 152 - Allogeneic Stem Cell Transplantation from Haploidentical Versus Matched Sibling Donors for Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
27. Effects of replacement fluids on coagulation system used for therapeutic plasma exchange
28. Malpositioning of Hickman catheters, left versus right sided attempts
29. The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cell transplantation
30. 269 - Non-T-Cell Depleted Haploidentical Stem Cell Transplantation (haploHCT) with Post Transplantation Cyclophosphamide (PTCy)- the Role of Donor Kinship: From the ALWP of the EBMT
31. 145 - MRD Status Impact on Secondary Acute Myeloid Leukemia Outcomes after Allogeneic Hematopoietic Cell Transplantation. A Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
32. National survey of hemapheresis practice in Turkey (1998)
33. Use of Post-Transplant Cyclophosphamide in One-Antigen Mismatched Unrelated Donor Transplantation Results in Similar Transplant Outcomes Than Haploidentical Hransplantation: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the EBMT
34. Differences in Liver Pathology and Clinical Outcome Between Two Patients with Hepatitis B Virus and Graft Versus Host Disease
35. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: A focus on the incidence of graft-vs.-host disease and relapse
36. The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation
37. Impact of an Established National Donor Registry on Transplant Outcome: Turkok Experience in Turkey
38. Allogeneic Hematopoietic Cell Transplantation (AHCT) in Post Infusion Cyclophosphamide (PIC) Era: The Switch from Anti-Thymocyte Globulin (ATG) to PIC for Graft Versus Host Disease (GVHD) Prophylaxis in AHCT from Alternative Donors
39. Safety and Efficacy of Autologous Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients - the Diadem Study from the Chronic Malignancies Working Party of the EBMT
40. Outcome of Patients with Hodgkin Lymphoma Treated with Brentuximab Vedotin for Relapse after Autologous Stem Cell Transplant: A Retrospective Analysis of the LWP-EBMT
41. Haploidentical Versus Unrelated Donor Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia: Single Center Experience
42. Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors — a Retrospective Study By the EBMT Chronic Malignancies Working Party
43. Comparing Conditioning Regimens for Autologous Stem Cell Transplantation in Lymphoma Patients
44. 498 - Is There Any Room for Allogeneic Hematopoetic Stem Cell Transplantation in Relapse/Refractory Lymphoma: Single Center Experience
45. 424 - Should We Start Peripheral Blood Stem Cell Collection for Allogeneic Transplantation on the Fifth Day?
46. The Impact of Foundation of the National Turkish Donor Registry, Turkok on Donor Matching Kinetics
47. Validation of Scores Predicting Non-Relapse Mortality in Patients with Myelodysplastic Syndrome: A Study on 1276 Patients on Behalf the Chronic Malignancies Working Party of the EBMT
48. Impact of In Vivo T-Cell Depletion in Patients with Myelodysplastic Syndromes Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Registry Study from the Chronic Malignancies Working Party of the EBMT
49. 352 - Allogenenic Hematopoetic Cell Transplantation in AML at CR1: Related vs Unrelated vs Haploidentical Donors
50. Influence of Past Invasive Fungal Infections on Allogeneic Related Donor Hematopoietic Cell Transplantation Outcome in AML
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.